Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis
Chiesi Global Rare Diseases announced today that the US Food and Drug Administration (FDA) has […]
ARX517 Shows Encouraging Single-Agent Safety and Efficacy Data in Patients with Advanced Prostate Cancer
Ambrx Biopharma today announced encouraging initial data from its ongoing Phase 1 trial investigating ARX517, […]
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership
LIfT BioSciences, a pioneering pre-clinical stage company moving into first-in-human trials with an allogeneic neutrophil […]
Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
Axcella Therapeutics, a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted […]
Investigational Therapy UGN-102 May Be Delivered at Home for the Treatment of Bladder Cancer
UroGen Pharma, a biotech company dedicated to developing and commercializing innovative treatment of urothelial and […]
Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine
Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]
First Baby Receives Life-Saving Gene Therapy on NHS
A 19-month-old baby girl called Teddi has become the first child in the UK to […]
Avidity Biosciences Receives FDA Orphan Drug Designation for AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy
Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called […]
BiPER Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-class Small Molecules to Treat Gastrointestinal Cancers
BiPER Therapeutics, a preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat […]
Veritas and Jeffrey Modell Foundation Announce a Collaboration to Help Advance Early Diagnosis in Children with Primary Immunodeficiencies
The Jeffrey Modell Foundation (JMF) a global non-profit organization for Primary Immunodeficiency (PI) and Veritas, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more